Tezepelumab in Adults with Uncontrolled Asthma
Authors:
Top Cited Papers
- 7 September 2017
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 377 (10) , 936-946
Abstract
In some patients with moderate-to-severe asthma, particularly those with noneosinophilic inflammation, the disease remains uncontrolled. This trial evaluated the efficacy and safety of tezepelumab (AMG 157/MEDI9929), a human monoclonal antibody specific for the epithelial-cell–derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled despite treatment with long-acting beta-agonists and medium-to-high doses of inhaled glucocorticoids.Keywords
This publication has 39 references indexed in Scilit:
- TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin InflammationScience Translational Medicine, 2013
- Global asthma prevalence in adults: findings from the cross-sectional world health surveyBMC Public Health, 2012
- Lebrikizumab Treatment in Adults with AsthmaNew England Journal of Medicine, 2011
- TSLP enhances the function of helper type 2 cellsEuropean Journal of Immunology, 2011
- Sensing the outside world: TSLP regulates barrier immunityNature Immunology, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Diesel Exhaust Particle-Exposed Human Bronchial Epithelial Cells Induce Dendritic Cell Maturation and Polarization via Thymic Stromal LymphopoietinJournal of Clinical Immunology, 2007
- Differential Role of Thymic Stromal Lymphopoietin in the Induction of Airway Hyperreactivity and Th2 Immune Response in Antigen-Induced Asthma with Respect to Natural Killer T Cell FunctionInternational Archives of Allergy and Immunology, 2007
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsJournal of Experimental Medicine, 2007
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002